1. FDA grants priority review to Roche's lung cancer drug Tecentriq — Teva drug fails in pediatric Tourette syndrome trial — GSK pays $50M for two solid tumor cell therapies from Immatics — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Molnlycke

Anonymous board for Molnlycke


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    7
    Views:
    2,546
  2. anonymous
    Replies:
    18
    Views:
    7,076
  3. anonymous
    Replies:
    1
    Views:
    1,178
  4. anonymous
    Replies:
    4
    Views:
    2,145
  5. Anonymous
    Replies:
    16
    Views:
    8,518
  6. anonymous
    Replies:
    3
    Views:
    3,544
  7. anonymous
    Replies:
    0
    Views:
    1,623
  8. anonymous
    Replies:
    1
    Views:
    2,479
  9. anonymous
    Replies:
    2
    Views:
    2,679
  10. Anonymous
    Replies:
    20
    Views:
    17,178
  11. Anonymous
    Replies:
    6
    Views:
    4,293
  12. Anonymous
    Replies:
    6
    Views:
    5,008
  13. Anonymous
    Replies:
    7
    Views:
    4,632
  14. Anonymous
    Replies:
    2
    Views:
    3,980
  15. Anonymous
    Replies:
    21
    Views:
    13,822
  16. Anonymous
    Replies:
    17
    Views:
    13,571
  17. Anonymous
    Replies:
    2
    Views:
    5,368
  18. Anonymous
    Replies:
    0
    Views:
    2,586
  19. Anonymous
    Replies:
    0
    Views:
    2,904
  20. Anonymous
    Replies:
    0
    Views:
    2,587

Thread Display Options

Loading...